PGEN:NASDAQPrecigen, Inc. Analysis

At $7.42, Precigen, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 44.9%. RSI sits at 65.8, which reads as approaching overbought, and MACD momentum is bullish. Price has been bracketed by support at $5.38 and resistance at $7.72.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 95.4% above where the shares trade now. Revenue is growing at 6322.7% on a -184.0% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 63.5%, a beta of 1.33 and a maximum drawdown of 40.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.